4//SEC Filing
CROWLEY Richard 4
Accession 0001181431-13-015374
CIK 0000722104other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:46 PM ET
Size
9.6 KB
Accession
0001181431-13-015374
Insider Transaction Report
Form 4
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
- Award
Option to Purchase Common Stock
2013-03-05+110,000→ 110,000 totalExercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying) - Award
Option to Purchase Common Stock
2013-03-05+100,000→ 100,000 totalExercise: $2.26Exp: 2022-02-01→ Common Stock (100,000 underlying) - Award
Option to Purchase Common Stock
2012-03-05+25,000→ 25,000 totalExercise: $11.62Exp: 2021-04-30→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
- [F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
- [F3]These options reflect the vesting of performance options that were granted to the reporting person effective April 30, 2011.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001352961
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:46 PM ET
- Size
- 9.6 KB